medical devices and innovations

The rollout follows the device’s receipt of both CE mark and UK Conformity Assessed (UKCA) certification, allowing hospitals and healthcare providers in eligible European countries to begin purchasing the system.

The test detects the virus by identifying its genetic material in blood samples, allowing health workers to confirm infections quickly and accurately.

The Jasper, Indiana-based electronics and medical contract manufacturer will add Helvoet’s facilities in Tilburg, the Netherlands, and in Pune, India, to its global manufacturing network.

Unlike conventional sequencing technologies, Axelios 1 uses SBX chemistry to convert DNA or RNA molecules into enlarged surrogate polymers known as Xpandomers.

Developed by Geneoscopy and offered commercially through Labcorp, ColoSense is intended for adults aged 45 to 85 years who are considered to have an average risk of colorectal cancer.

The new system increases the Mega Lab’s haematology testing capacity to more than 1,000 tests per hour while reducing manual handling throughout the testing workflow.

The move marks an important step toward evaluating the technology for Good Manufacturing Practice (GMP)-compliant manufacturing while improving the efficiency of producing next-generation medicines.

Scientia Vascular develops advanced access products designed to improve simplicity and precision during neurovascular interventions.

The researchers designed the device to work seamlessly with existing medical imaging technologies, including ultrasound and CT scans.

The capsule uses advanced light-absorption technology to detect blood in the upper gastrointestinal tract and wirelessly transmits the findings to an external receiver, which is monitored by healthcare professionals.